Follitropin Alfa Injection: Uses, Dosage, and Side Effects Guide

Summary or Key Points

Follitropin Alfa is a medication used to treat infertility and other reproductive health conditions. It is a synthetic form of the hormone FSH (follicle-stimulating hormone), which stimulates the ovaries or testes to produce eggs or sperm. This medication is commonly used in assisted reproductive technologies (ART), such as in vitro fertilization (IVF). Always consult your healthcare provider before starting or adjusting your dose of Follitropin Alfa injection.

Names of Medication

US Brand Name: Gonal-f® (Follitropin Alfa)

The generic name refers to the chemical composition of the drug, while the brand name is assigned by the manufacturer. In this case, Follitropin Alfa is the generic name.

Pharmacologic Category

Categories:

1. Gonadotropins
2. Follicle-Stimulating Hormones (FSH)

Follitropin Alfa Dosage

Follitropin Alfa is prescribed for various reproductive health conditions, with dosing tailored to the specific condition. Always consult your doctor before making any changes to your dose. If you need to speak with a healthcare provider, you can schedule a telemedicine appointment with one of our specialists.

Infertility (Female)

Initial Dose: 75 to 150 international units (IU) injected under the skin once daily.

Frequency: Daily.

Length of Treatment: Typically 7 to 14 days, depending on your response. Your doctor may adjust the dose based on hormone levels and ovarian response.

Ovulation Induction (Anovulation)

Initial Dose: 75 IU injected under the skin once daily.

Frequency: Daily.

Length of Treatment: Usually 7 to 14 days, but your doctor may extend treatment based on your response.

Assisted Reproductive Technology (ART)

Initial Dose: 150 to 225 IU injected under the skin once daily.

Frequency: Daily.

Length of Treatment: Typically 7 to 14 days, depending on your response.

Male Factor Infertility (Hypogonadism)

Initial Dose: 150 IU injected under the skin three times per week.

Frequency: Three times per week.

Length of Treatment: Treatment may last several months, depending on sperm production response.

Dosage Forms and Strengths

Follitropin Alfa is available in the following forms:

1. Injection: 300 IU/0.5 mL prefilled pen
2. Injection: 450 IU/0.75 mL prefilled pen
3. Injection: 900 IU/1.5 mL prefilled pen

Follitropin Alfa Administration Instructions

Follitropin Alfa is administered via subcutaneous injection. Follow your healthcare provider’s instructions carefully on how to inject the medication. You may be trained to self-administer at home. Be sure to rotate injection sites to minimize irritation. If you miss a dose, contact your healthcare provider for guidance.

Follitropin Alfa Side Effects

Like all medications, Follitropin Alfa may cause side effects. Some are mild, while others may require immediate medical attention. If you experience any side effects, contact your healthcare provider or schedule a telemedicine visit with one of our specialists.

Common Side Effects

Headache: Mild headaches may occur as your body adjusts to the medication.

Abdominal Pain: Some patients experience mild to moderate abdominal discomfort.

Injection Site Reactions: Redness, swelling, or pain at the injection site is common.

Less Common but Serious Side Effects

Ovarian Hyperstimulation Syndrome (OHSS): A rare but serious condition where the ovaries become swollen and painful. Symptoms include severe abdominal pain, nausea, and rapid weight gain. Seek immediate medical attention if you experience these symptoms.

Blood Clots: In rare cases, Follitropin Alfa can increase the risk of blood clots. Symptoms include swelling, leg pain, or difficulty breathing.

Contraindications for Follitropin Alfa

A contraindication is a specific condition where a medication should not be used because it may cause harm. If you have any of the following conditions, you should not take Follitropin Alfa, as it could lead to serious health complications.

Primary Ovarian Failure: Follitropin Alfa is ineffective in patients with primary ovarian failure, where the ovaries no longer function properly. Using this medication will not result in ovulation.

Uncontrolled Thyroid or Adrenal Dysfunction: Hormonal imbalances from thyroid or adrenal disorders can interfere with Follitropin Alfa’s effectiveness and may worsen your condition.

Pregnancy: Follitropin Alfa should not be used during pregnancy, as it is intended to stimulate ovulation, which is unnecessary once conception has occurred.

Ovarian Cysts or Enlargement (not due to Polycystic Ovary Syndrome): Enlarged ovaries or ovarian cysts can worsen with Follitropin Alfa, leading to complications like ovarian hyperstimulation syndrome (OHSS).

Unexplained Uterine Bleeding: If you have unexplained vaginal bleeding, it is important to rule out serious conditions like cancer before starting Follitropin Alfa.

Hypersensitivity to Follitropin Alfa or its Ingredients: If you have had allergic reactions to Follitropin Alfa or any of its components, avoid this medication to prevent severe allergic reactions.

Drug to Drug Interactions

Certain medications may interact with Follitropin Alfa, potentially affecting its effectiveness or increasing the likelihood of side effects. It’s important to inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Some known interactions include:

Clomiphene Citrate (Clomid): Commonly used to stimulate ovulation, this medication may heighten the risk of ovarian hyperstimulation syndrome (OHSS) when combined with Follitropin Alfa.

Gonadotropin-Releasing Hormone Agonists (Lupron): These medications help regulate hormone levels. When used alongside Follitropin Alfa, dose adjustments may be required to prevent ovarian overstimulation.

Human Chorionic Gonadotropin (hCG) (Pregnyl, Ovidrel): hCG is often administered with Follitropin Alfa to trigger ovulation. However, incorrect timing or dosage can increase the risk of OHSS.

Follitropin Alfa in Pregnancy

Is it Safe to Take Follitropin Alfa During Pregnancy?

No, Follitropin Alfa should not be used during pregnancy. This medication stimulates the ovaries to produce eggs, which is unnecessary and potentially harmful once pregnancy has occurred. If you become pregnant while taking Follitropin Alfa, discontinue use immediately and consult your healthcare provider. If you are unsure about your pregnancy status, take a test before continuing treatment.

Follitropin Alfa While Breastfeeding

Is it Safe to Take Follitropin Alfa While Breastfeeding?

There is limited information on whether Follitropin Alfa passes into breast milk or its potential effects on a breastfeeding infant. Due to the lack of conclusive data, it is generally advised to avoid using Follitropin Alfa while breastfeeding. If you are breastfeeding and considering fertility treatments, consult your healthcare provider to determine the safest approach.

Estimated Cost of Follitropin Alfa

The cost of Follitropin Alfa can vary depending on the pharmacy and location. With a GoodRX coupon, a 30-day supply without insurance is estimated to range between $1,500 and $3,000. Prices may fluctuate, so it’s a good idea to check with your pharmacy and explore discount programs or coupons to help reduce costs.

Possible Alternatives to Follitropin Alfa

If Follitropin Alfa is not suitable for you, there are alternative treatments and lifestyle changes that may help manage your condition. Always discuss these options with your healthcare provider before making any changes to your treatment plan. You can also consult one of our providers through telemedicine for personalized advice.

1. Infertility: Alternatives include Clomiphene Citrate (Clomid), Letrozole (Femara), or intrauterine insemination (IUI). Lifestyle changes such as maintaining a healthy weight, reducing stress, and avoiding smoking or excessive alcohol consumption may also improve fertility.
2. Hypogonadism: Testosterone replacement therapy or human chorionic gonadotropin (hCG) may be considered. Regular exercise and a balanced diet can also help manage symptoms.
3. Ovarian Dysfunction: Fertility medications like Letrozole or Clomiphene Citrate may be options. Addressing underlying conditions, such as thyroid disorders, can also improve ovarian function.
4. Polycystic Ovary Syndrome (PCOS): Lifestyle changes such as weight loss, a low-carbohydrate diet, and regular exercise can help alleviate symptoms. Medications like Metformin or Letrozole may also be effective.
5. Anovulation: Clomiphene Citrate or Letrozole are common alternatives. Addressing hormonal imbalances or managing stress can also help restore ovulation.
6. Testicular Failure: Testosterone replacement therapy or assisted reproductive technologies (ART), such as sperm donation, may be considered.
7. Primary Ovarian Insufficiency: Hormone replacement therapy (HRT) or donor egg IVF may be options. Lifestyle changes such as stress management and maintaining a healthy weight can also be beneficial.
8. Male Factor Infertility: Treatments may include intrauterine insemination (IUI), in vitro fertilization (IVF), or lifestyle changes such as quitting smoking, reducing alcohol intake, and improving diet and exercise habits.
9. Assisted Reproductive Technology (ART): Alternatives include IVF with donor eggs or sperm, or surrogacy. Discuss with your provider to determine the best ART option for you.
10. Ovulation Induction: Clomiphene Citrate or Letrozole may be used as alternatives. In some cases, lifestyle changes such as weight loss or stress management can help induce ovulation naturally.

Recent Updates on Follitropin Alfa Research

Recent studies on Follitropin Alfa have focused on optimizing dosing regimens to reduce the risk of ovarian hyperstimulation syndrome (OHSS) while maintaining high success rates in ovulation induction and assisted reproductive technologies (ART). Researchers are also exploring personalized dosing based on genetic markers to improve fertility treatment outcomes. Additionally, ongoing studies are investigating the long-term safety of Follitropin Alfa in women undergoing multiple ART cycles. As research continues to evolve, stay informed and discuss any new findings with your healthcare provider.

James Kingsley

Learn More